Why New Hair Grows In Thinner After Menopause, What the Research Shows

In this article
- Why does new hair come in thinner after menopause?
- What is the anagen phase, and why does it decide hair thickness?
- What does the 2024 estrogen-hair research actually say?
- Where does shilajit's own research connect to this signal?
- How does this compare with what usually gets recommended for thin hair?
- What actually supports hair diameter day to day?
- Common questions about hair diameter and shilajit after menopause
Why does new hair come in thinner after menopause?

Most hair conversations start with counting. How many hairs are on the pillow, how many are left in the ponytail, how much scalp shows through in a part that used to hide it. Those are real questions, and they matter.
But there is a second, quieter question underneath the first one. Of the hair that is still growing, is each new strand as thick as the one it replaced? For a lot of women past 50, the honest answer is no, and that is a different mechanism than shedding.
Two separate problems wearing the same name
Hair loss after menopause tends to get treated as one problem. In the follicle, it is closer to two. One is about how many follicles are actively growing at a given time, which shows up as thinning density. The other is about how long each growing follicle stays in its building phase before it stops, which shows up as the caliber of the strand itself. A follicle can keep producing hair and still produce something visibly finer than it used to.
What is the anagen phase, and why does it decide hair thickness?
Every hair follicle runs on a cycle with three stages. Anagen is the active growth phase, when the follicle is dividing cells and building the shaft. Catagen is a short transition. Telogen is the resting phase, when the old hair eventually releases.
- Anagen can last anywhere from two to seven years on a healthy scalp follicle
- The longer a follicle stays in anagen, the longer and generally thicker the hair it produces
- A shortened anagen phase means the follicle exits the building stage earlier, before the shaft reaches its full potential caliber
- Telogen and catagen are comparatively brief and do not add material to the shaft
A follicle that has shifted toward a shorter anagen phase is not necessarily dying. It is still cycling, still producing hair, just producing something finer each time around, which is why this can be easy to miss until the difference has been compounding for a while.
Why this matters more than it sounds
A woman who checks for shedding and finds a normal amount on her brush can still be losing visible fullness, because the metric that changed was never hair count in the first place. It was the build time each strand was given.
What does the 2024 estrogen-hair research actually say?

The clearest statement of this mechanism comes from a 2024 review in Biomedicines, led by researcher Karolina Owecka and colleagues, examining the hormonal background of hair loss. The review is not a shilajit study. It is a synthesis of the endocrinology literature on hair, and it names menopause specifically as the most common cause of estrogen deficiency severe enough to affect hair.
Three findings from that review carry the weight here.
- Estrogen receptor beta is present in the hair follicle itself, giving estrogen a direct physical point of contact with the structure that builds each strand
- Estradiol is reported to extend the anagen phase of the hair cycle, the active growth stage described above
- The review states that estrogens are assumed to promote hair growth, increase hair diameter, and prevent hair loss, tying the mechanism to strand thickness in its own words, not diameter as an inference
That third point is the one most hair content skips. Diameter gets treated as a cosmetic detail rather than a direct output of the same hormonal signal that governs whether hair grows at all.
What the review does not claim
The review is a synthesis of existing endocrinology research, not a new clinical trial, and it does not test any supplement, including shilajit. It establishes the mechanism connecting estrogen to hair diameter. It does not test what happens when a woman intervenes on that signal from outside the body.
Where does shilajit's own research connect to this signal?
Shilajit is not a hormone. It does not add estrogen or replace it. What its human research shows is activity on the body's own estrogen signaling and on the collagen materials a follicle needs to build a shaft, which is a different claim than a hair-growth result, and we want to be precise about which is which.
- A 48-week randomized controlled trial in postmenopausal women found shilajit affected markers tied to the body's estrogen-signaling axis, the same general signaling system the anagen-phase mechanism above depends on
- An 8-week human trial in adults found shilajit upregulated a cluster of 17 extracellular matrix and collagen genes in muscle tissue, including a more than fivefold rise in one collagen gene specifically
- A separate 14-week human trial in women found shilajit improved skin perfusion and upregulated blood-vessel and structural genes, evidence that its effect on human tissue signaling has been measured in women directly, not only inferred from a male or mixed-sex study
- None of these three trials measured hair diameter, hair growth, or any outcome specific to the scalp
The honest gap is real, and naming it matters more than smoothing it over. No dedicated human trial has tested shilajit against hair shaft diameter. What exists is a body of separate research showing shilajit is biologically active on the same signaling and structural systems the anagen-phase mechanism runs on, in postmenopausal women specifically, which is meaningfully different from a direct hair result.
Where the material leg comes in
Bamboo silica, the third component alongside shilajit in Optimum's Trifecta formula, has its own separate human evidence, a randomized controlled trial that reduced measures of hair and nail brittleness over several months. Silicon supports the structural crosslinking of collagen, the material a follicle uses once the signal tells it to build. Signal and material are two different jobs, and the research for each sits in a different study.
How does this compare with what usually gets recommended for thin hair?
Most thinning-hair advice targets the visible symptom directly, through volumizing products or topical growth treatments. The research above points at something upstream of both.
| Volumizing products | Topical growth treatments | Estrogen-signal research | |
|---|---|---|---|
| What it targets | The appearance of the existing strand | Local blood flow to the follicle | The anagen-phase length itself |
| Effect on new growth | None, cosmetic only | Can extend growth in some users | Mechanism-level, not yet a shilajit-specific trial |
| Duration of effect | Washes out | Reverses within months of stopping | Structural, ongoing signal support |
| Evidence for shilajit specifically | Not applicable | Not applicable | Estrogen-signaling RCT plus collagen-gene trials, no direct hair trial |
None of these fully replace the others, and the honest reading of the research is that a topical approach and a signal-and-material approach are solving for different parts of the same follicle, not competing solutions.
What actually supports hair diameter day to day?

A few habits work on the same systems this research describes, independent of any supplement.
- Handle wet hair gently, since the shaft is weakest and most prone to snapping when saturated, which compounds any diameter loss that is already happening
- Get enough protein daily, since the hair shaft is built almost entirely from keratin protein and a shortfall shows up in shaft quality over months
- Limit high-heat styling on strands that are already coming in finer, since heat damage concentrates its effect on the thinnest part of the shaft
- Keep iron and thyroid levels checked with a healthcare provider, since both are common, correctable contributors to hair changes that mimic a hormonal cause
- Give any structural intervention several full growth cycles, since a strand started today will not show its full caliber for months
Shilajit's fulvic acid content is the mechanism behind the estrogen-signaling research described above, and it is one of three ingredients in the Optimum Shilajit Trifecta, paired with pearl powder and bamboo silica around the signal-and-material process this article describes. No dedicated human trial has tested it against hair diameter directly, and we say that plainly rather than imply a result the research has not shown.
Common questions about hair diameter and shilajit after menopause
Is this the same as hair shedding or thinning?
No. Shedding is about how many hairs fall and how many grow back. This is about the caliber of the individual hair that does grow back, which is a separate question governed by how long the follicle spends in its active growth phase.
What is the anagen phase?
The anagen phase is the active growth stage of the hair cycle, when the follicle is actively producing the shaft. A longer anagen phase generally means a longer, thicker hair. A shorter one means the follicle stops building sooner.
Does shilajit add estrogen to the body?
No. Shilajit is not a hormone. It supports the body's own estrogen signaling rather than adding estrogen or replacing it, which is a different mechanism than hormone therapy.
Has shilajit been tested directly on hair diameter?
No dedicated human trial has measured shilajit against hair shaft diameter. What exists is a human RCT showing shilajit affects the same estrogen-signaling axis the anagen-phase research describes, plus separate human trials on the collagen and silicon materials the follicle needs to build a shaft. We say plainly where the direct evidence ends.
Is shilajit safe to take alongside other hair treatments?
Shilajit is not a hormone and does not interact with topical treatments the way a systemic drug can. Across human clinical studies on shilajit, zero serious adverse events have been reported. Optimum shilajit is Altai sourced, independent third-party lab tested, and heavy metal free.
Sources
- Owecka K, et al. Hormonal Background of Hair Loss in Non-Scarring Alopecias. Biomedicines, 2024. https://pubmed.ncbi.nlm.nih.gov/38540126/
- Pingali U, et al. Effect of standardized shilajit in patients with osteopenia and osteoporosis. PMID 35933897. https://pubmed.ncbi.nlm.nih.gov/35933897/
- Das A, et al. Skeletal muscle transcriptome response to shilajit supplementation. PMID 27414521. https://pubmed.ncbi.nlm.nih.gov/27414521/
- Das A, et al. Effect of shilajit on skin perfusion and gene expression in women. PMID 31161927. https://pubmed.ncbi.nlm.nih.gov/31161927/
- Wickett RR, et al. Effect of choline-stabilized orthosilicic acid on hair and nail brittleness. PMID 17960402. https://pubmed.ncbi.nlm.nih.gov/17960402/